Have a question or topic idea for The Life Science Report? Submit it here.
Healthcare Development News - What’s Happening in Renal Disease
Airdate: November 7, 2023
With our latest episode of The Life Science Report we turn our focus towards the chronic and rare disease angle of kidney disease. Recently, there have been some changes in treatment, notable commercial launches and growing interest in the area from pharma consolidators.
Back Bay’s Dr. Pete Bak and Christian Thienel walk us through the evolution of the field and various aspects of the renal disease landscape. Topics in this podcast include:
The links between cardio and metabolic diseases and the therapeutic approaches and label expansions taking place in the renal disease landscape
The impact of Sodium-glucose cotransporter-2s (SGLT2s) in kidney disease over these last five or six years, and how they affect standard of care and end stage renal disease
Historic evolutions beyond Chronic Kidney Disease (CKD), from rare diseases to all types of indications of CKD
Understanding potential treatment priorities when some therapies have benefits in multiple indications
Recent deals, including Novartis’ acquisition of Chinook Therapeutics and Novo Nordisk’s acquisition of KBP Biosciences’ ocedurenone, etc.
Listen to the full episode here.
Subscribe:
Apple Podcasts | Libsyn | Spotify | Stitcher